Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

October 5, 2025

Study Completion Date

December 31, 2027

Conditions

Ventricular ArrythmiaVentricular FibrillationVentricular Tachycardia

Interventions

DEVICE

Atala™ lead

Subjects will receive the Atala™ lead being evaluated in the study.

Trial Locations (3)

University Hospital Center Split, Split

Christchurch Hospital, Christchurch

Sanatorio Italiano, Asunción